Brendan DePoe
Associate | Vancouver
Vancouver: 604-631-5242

Brendan's practice focuses on corporate and securities law matters, including cross-border mergers and acquisitions, corporate reorganizations, corporate finance and corporate governance. He also advises clients on stock exchange matters, securities regulatory compliance and general corporate law.

Brendan has experience advising clients in the mining, natural resources, private equity, life sciences and technology sectors.

Brendan previously worked for 18 months in the Firm’s London office.


Recent representative transactions include acting for:

  • Trilogy International Partners on a US$875-million business combination with Alignvest Acquisition Corporation, a special purpose acquisition corporation (SPAC)

  • GB Minerals on its acquisition by Itafos

  • ESSA Pharma in connection with its acquisition of Realm Therapeutics

  • Helius Medical in connection with its C$10.2-million prospectus offering and its listing on the Toronto Stock Exchange

  • True Gold in connection with its acquisition by Endeavour Mining for C$191-million

  • The underwriter in connection with a C$30-million private placement offering of common shares of First Majestic Silver Corp.

  • Romarco Minerals Inc. in connection with its acquisition by OceanaGold Corporation for C$856-million of common shares of OceanaGold Corporation

  • Aequus Pharmaceuticals in connection with its special warrant prospectus offering and subsequent listing on the TSX Venture Exchange

  • Romarco Minerals Inc. with its public offering of C$300-million of common shares

  • Various public and private companies in connection with brokered and non-brokered private placements of common shares, flow-through shares, units and warrants

  • Secondary listings and corporate governance advice for various TSX and TSX-V issuers